Recombinant soluble CD40 ligand polypeptide and pharmaceutical c

Details Recombinant soluble CD40 ligand polypeptide and pharmaceutical c Recombinant soluble CD40 ligand polypeptide and pharmaceutical c

1995-06-07

1999-10-05

Chan, Christina Y.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514885, 514 12, 530350, 536 231, 536 234, 536 235, A61K 3818, C07K 14435

Patent

active

059624060

ABSTRACT:
There is disclosed a polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor.

REFERENCES:
patent: 5182368 (1993-01-01), Ledbetter et al.
patent: 5247069 (1993-09-01), Ledbetter et al.
patent: 5474771 (1995-12-01), Lederman et al.
patent: 5540926 (1996-07-01), Aruffo et al.
patent: 5565321 (1996-10-01), Spriggs et al.
patent: 5716805 (1998-02-01), Srinivasan
patent: 5817516 (1998-10-01), Kehry et al.
Noelle et al. Immunology Today 13:431-433 (1992).
Graf et al. Eur. J. Immunol. 22:3191-3194 (1992).
Lederman et al. J Exp Med. 175:1091-1101 (1992).
Ostlund et al. In Encyclopedia of Immunology, Roitt and Delves, Eds., Academic Press, 1992, pp. 776-778.
Conney et al. Mol. Immunol. 31:471-484 (1994).
Aruffo and Seed, Proc. Natl. Acad Sci. USA 84:8573, 1987.
Stamenkovic et al., EMBO J.8:1403, 1989.
Zettlmeissl et al., DNA Cell. Biol 9:347, 1990.
Banchereau et al., Science 251:70, 1991.
Rousset et al., J. Exp. Med. 173:705, 1991.
Banchereau and Rousset, Clinical Immunology Spectrum 3:9, 1991.
Liu et al., Nature 342:929, 1989.
Ghaderi et al., Immunology 73:510, 1991.
Kikutani et al., Cell 47:657, 1986.
Wang et al., J. Virol. 65:4101, 1991.
Valle et al., Eur. J. Immunol. 19:1463, 1989.
Clark et al., Proc. Natl. Acad. Sci. USA 83:4494, 1986.
Paulie et al., J. Immunol. 142:590, 1989.
Gordon et al., Eur. J. Immunol. 17:1535, 1987.
Jabara et al., J. Exp. Med. 172:1861, 1990.
Zhang et al., J. Immunol. 146:1836, 1991.
Gascan et al., J. Immunol. 147:8, 1991.
Gordon et al., J. Immunol. 140:1425, 1988.
Armitage et al., Nature 357:80, 1992.
Fanslow et al., J. Immunol. 149:655, 1992.
Spriggs et al., J. Exp. Med. 176:1543, 1992.
Farrah and Smith, Nature 358:26, 1992.
Noelle et al., Proc. Natl. Acad. Sci USA 89:6550, 1992.
Hollenbaugh et al., EMBO J. 11:4313, 1992.
Durie et al., Science 261:1328; 1993.
Lauzon et al., Mol. Immunol. 25:829; 1988.
Potocnik et al., Scan. J. Immunol. 31:213; 1990.

Affiliated with

Also associated with

Rating

Recombinant soluble CD40 ligand polypeptide and pharmaceutical c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant soluble CD40 ligand polypeptide and pharmaceutical c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant soluble CD40 ligand polypeptide and pharmaceutical c will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1171393